Pour L - Search Results

1

Langerhans cell histiocytosis (LCH). Overview of symptoms of LCH, which may lead the patients to any of these medical specialists.

Adam Z, Pour L, Tomíška M, Starý K, Horváth T, Doubková M, Nebeský T, Řehák Z, Koukalová R, Krejčí M, Krejčí M, Boichuk I, Štork M, Ševčíková S, Adamová Z, Král Z. Adam Z, et al. Among authors: pour l. Vnitr Lek. 2022 Summer;68(E-2):11-21. Vnitr Lek. 2022. PMID: 36208940 English.

2

Lenalidomide: a new treatment option for Castleman disease.

Szturz P, Adam Z, Chovancová J, Stehlíková O, Klabusay M, Rehák Z, Koukalová R, Krejčí M, Pour L, Zahradová L, Hájek R, Mayer J. Szturz P, et al. Among authors: pour l. Leuk Lymphoma. 2012 Oct;53(10):2089-91. doi: 10.3109/10428194.2011.621564. Epub 2011 Dec 5. Leuk Lymphoma. 2012. PMID: 21902577 No abstract available.

3

Lenalidomide proved effective in multisystem Langerhans cell histiocytosis.

Szturz P, Adam Z, Rehák Z, Koukalová R, Slaisová R, Stehlíková O, Chovancová J, Klabusay M, Krejčí M, Pour L, Hájek R, Mayer J. Szturz P, et al. Among authors: pour l. Acta Oncol. 2012 Mar;51(3):412-5. doi: 10.3109/0284186X.2011.631581. Epub 2011 Nov 21. Acta Oncol. 2012. PMID: 22103591 No abstract available.

4

Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma.

Szturz P, Řehák Z, Koukalová R, Adam Z, Krejčí M, Pour L, Zahradová L, Vaníček J, Nebeský T, Hájek R, Mayer J. Szturz P, et al. Among authors: pour l. Nucl Med Biol. 2012 Apr;39(3):429-36. doi: 10.1016/j.nucmedbio.2011.10.002. Epub 2011 Dec 14. Nucl Med Biol. 2012. PMID: 22172385 Free article.

5

Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.

Adam Z, Szturz P, Vaníček J, Moulis M, Pour L, Krejčí M, Hájek R, Mayer J. Adam Z, et al. Among authors: pour l. Acta Oncol. 2013 Jun;52(5):994-1001. doi: 10.3109/0284186X.2012.716164. Epub 2012 Aug 31. Acta Oncol. 2013. PMID: 22937955

6

[Therapy of Waldenström´s macroglobulinaemia in the year 2014].

Adam Z, Krejčí M, Pour L, Ševčíková E. Adam Z, et al. Among authors: pour l. Vnitr Lek. 2014 Feb;60(2):139-57. Vnitr Lek. 2014. PMID: 24754419 Review. Czech.

7

[PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].

Adam Z, Řehák Z, Koukalová R, Bortlíček Z, Krejčí M, Pour L, Szturz P, Prášek J, Nebeský T, Adamová Z, Král Z, Mayer J. Adam Z, et al. Among authors: pour l. Vnitr Lek. 2014 May-Jun;60(5-6):499, 501-11. Vnitr Lek. 2014. PMID: 24974755 Czech.

8

[Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].

Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S. Adam Z, et al. Among authors: pour l. Vnitr Lek. 2014 Oct;60(10):861-79. Vnitr Lek. 2014. PMID: 25382009 Review. Czech.

9

[PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].

Adam Z, Szturz P, Koukalová R, Řehák Z, Pour L, Krejčí M, Šmardová L, Eid M, Volfová P, Čermáková Z, Křen L, Sokol F, Hanke I, Michalková E, Král Z, Mayer J. Adam Z, et al. Among authors: pour l. Vnitr Lek. 2015 Mar;61(3):251-9. Vnitr Lek. 2015. PMID: 25873122 Review. Czech.

10

[Myopathy in patients with Waldenströms macroglobulinemia. A case study and an overview of autoimmune expressions of type IgM monoclonal immunoglobulins].

Adam Z, Kissová J, Pour L, Krejčí M, Ševčíková E, Koukalová R, Čermáková Z, Černá M, Král Z, Mayer J. Adam Z, et al. Among authors: pour l. Vnitr Lek. 2015 Sep;61(9):821-8. Vnitr Lek. 2015. PMID: 26465282 Review. Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page